Form 4: RHEP Director Kellman Granted 3,000 Stock Options

Regional Health Properties, Inc. Director F. Scott Kellman was granted 3,000 non-qualified stock options with an exercise price of $1.30, vesting immediately.

Summary

• F. Scott Kellman, a Director of Regional Health Properties, Inc. (RHEP), was granted 3,000 non-qualified stock options.
• The options have an exercise price of $1.30 per share.
• The exercise price was determined by the average of the high/low of RHEP common stock on the OTC market on January 16, 2026.
• The options vest immediately upon grant.
• The options expire on January 16, 2036.
• The grant was made pursuant to the company's Amended and Restated 2023 Omnibus Incentive Compensation Plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, as it aligns director incentives with shareholder interests, a standard corporate governance practice, without indicating any immediate operational changes.

Positives

• The grant of stock options aligns the director's interests with those of shareholders, incentivizing long-term performance.
• The immediate vesting of options provides immediate equity exposure and potential upside for the director.

Future Outlook

The options have a ten-year expiration period, allowing the director to benefit from potential long-term appreciation of RHEP's common stock.

Industry Context

StockSavvy.ai notes that granting stock options to directors is a common practice across industries, particularly in healthcare REITs like Regional Health Properties, Inc., to attract and retain talent and align leadership incentives with shareholder value creation. This practice is consistent with typical corporate governance structures aimed at fostering long-term commitment.

Comparison to Industry Standards

• The grant of 3,000 stock options to a director is a standard form of equity compensation. For example, similar grants are observed in other small-cap healthcare REITs, where director compensation often includes a mix of cash and equity to align interests.
• The immediate vesting of options is less common than phased vesting schedules but can be used to provide immediate equity exposure and commitment.
• The exercise price being based on the average high/low on the OTC market on the grant date is a standard valuation method for option grants.

Corporate Governance

Related Party Transactions

• The grant of stock options to F. Scott Kellman, a Director, constitutes a related party transaction as it involves compensation to an insider. This is a standard practice disclosed under SEC regulations.

Stakeholder Impact

• Shareholders: The grant of options aims to align the director's interests with shareholders, potentially leading to better long-term performance. However, future exercise of options could lead to minor dilution.
• Management/Directors: F. Scott Kellman receives additional equity compensation, increasing his stake and incentive in the company's success.

Next Steps

• The director may choose to exercise these options at any point between the vesting date (January 16, 2026) and the expiration date (January 16, 2036), assuming the stock price is above the exercise price.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction (stock option grant) to a director. While it aligns the director's interests with shareholders, it does not provide new material information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It is a standard disclosure of compensation under an existing incentive plan.

Keywords

Regional Health Properties, RHEP, F. Scott Kellman, stock options, Form 4, insider transaction, director compensation, equity incentive, OTC market